Australian Technical Advisory Group on Immunisation (ATAGI) Annual Statement on Immunisation 2023

The ATAGI 2023 Annual Statement on Immunisation is the third publication in this series. It covers key successes, trends and challenges in the use of vaccines and control of vaccine-preventable diseases in 2023. It also signals ATAGI’s priority actions for addressing key issues for 2023.

Scroll down to access downloads and media.

In 2022, governments across Australia eased COVID-19 pandemic-related community and border control measures. As social interactions increased, the rate of some common vaccine-preventable diseases, especially influenza, also grew. There were also significant outbreaks of 2 newly emerged diseases, Japanese encephalitis and mpox (formerly known as monkeypox). The responses to these new Communicable Disease Incidents of National Significance (CDINS) included establishing vaccination programs against these diseases.